Literature DB >> 10850422

Interaction between Sp1 and cell cycle regulatory proteins is important in transactivation of a differentiation-related gene.

O G Opitz1, A K Rustgi.   

Abstract

The stratified squamous epithelium is a model system in which to define molecular mechanisms underlying the switch from proliferation to differentiation. This can be achieved through the functional dissection of keratin gene promoters. Having previously established the importance of keratin 4 in maintaining the differentiated phenotype in corneal epithelial cells, we investigated the role of Sp1-mediated transactivation of the keratin 4 promoter given the role of Sp1 in differentiation and cell cycle progression. Sp1 transactivation of the keratin 4 promoter was diminished in cyclin D1-overexpressing cells, which may be mediated through a newly described direct interaction between Sp1 and cyclin D1 and opposed by a complex between Sp1 and pRB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850422

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase.

Authors:  Fei Zhou; Jianjie Hu; Haiyan Ma; Marietta L Harrison; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 2.  Sp1 phosphorylation and its regulation of gene transcription.

Authors:  Nicole Y Tan; Levon M Khachigian
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

3.  Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Authors:  Sarah L Doyle; Kari Ann Shirey; Anne F McGettrick; Elaine F Kenny; Susan Carpenter; Brian E Caffrey; Siobhan Gargan; Susan R Quinn; Jorge H Caamaño; Paul Moynagh; Stefanie N Vogel; Luke A O'Neill
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

4.  Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.

Authors:  Gwen E Dressing; Todd P Knutson; Matthew J Schiewer; Andrea R Daniel; Christy R Hagan; Caroline H Diep; Karen E Knudsen; Carol A Lange
Journal:  Mol Endocrinol       Date:  2014-02-25

Review 5.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

6.  Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor γ (PPARγ) during adipocyte differentiation.

Authors:  Debasish Roy; Kenneth T Farabaugh; Jing Wu; Alyssa Charrier; Cynthia Smas; Maria Hatzoglou; Kavitha Thirumurugan; David A Buchner
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

7.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

8.  Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.

Authors:  Lin Jin; Pran K Datta
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription.

Authors:  Jianyong Ding; Di Ge; Weigang Guo; Chunlai Lu
Journal:  Lung       Date:  2008-12-04       Impact factor: 2.584

Review 10.  Proteomic identification of a direct role for cyclin d1 in DNA damage repair.

Authors:  Siwanon Jirawatnotai; Yiduo Hu; David M Livingston; Piotr Sicinski
Journal:  Cancer Res       Date:  2012-08-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.